Objective: To assess, among people with HIV, the association of self-reported antiretroviral treatment (ART) and viral load status with condomless sex with an HIV-serodifferent partner (CLS-D).
Introduction
Transmission of HIV in the United Kingdom continues to be high among men who have sex with men (MSM) [1] [2] [3] . Among heterosexual men and women, transmission within the United Kingdom is also ongoing, despite a decline in overall number of new diagnoses because of migration patterns [1] . Although it is estimated that most new HIV infections in the United Kingdom are transmissions from people unaware that they have HIV [3, 4] , a significant proportion (an estimated 18% among MSM [3] ) are transmissions from people already diagnosed, indicating that prevention issues in this group remain important. Understanding patterns of sexual behaviour according to antiretroviral treatment (ART) use among people diagnosed with HIV has implications for clinical care and public health.
Recommendations on when (at what CD4
þ cell count) an individual with HIV should start ART have shifted, over time, towards earlier initiation of ART. For some years, interest has focused on a strategy of offering ART to all people with HIV, from diagnosis, irrespective of CD4 þ cell count [4, 5] , and such a policy was recommended in the United States in 2012 [6] . Until very recently, the main impetus for this strategy was the potential impact on transmission, based on compelling results regarding the profound reduction in infectiousness to sexual partners for HIV-positive people taking ARTwith suppressed viral load [7] [8] [9] [10] [11] [12] [13] , in particular from the HPTN052 trial in 2011 [12] , and the recent PARTNER study [13] . In May 2015, landmark results of the international START trial demonstrated that earlier ART also confers clinical prognostic benefit to the individual [14] . Consequently, treatment guidelines worldwide are being changed to recommend immediate ART for all people diagnosed with HIV [15, 16] . Such a strategy should reduce HIVrelated morbidity, and reduce HIV transmission.
A longstanding question is whether taking ART may influence an individual's sexual behaviour. This question is becoming increasingly relevant, as knowledge about the protective effect of ART on HIV infectiousness becomes established and widespread. The 'Swiss statement' [17] in 2008 marked the first fundamental change in advice about 'safe sex' for HIV-positive people, asserting (with caveats) that an HIV-positive person on ART with viral suppression is not sexually infectious. Subsequent results from the Swiss HIV Cohort study suggested higher levels of condomless sex (CLS) with stable partners of HIV-negative/unknown status among participants who were virally suppressed [18] . However, most studies carried out before [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] and soon after [30] [31] [32] [33] the Swiss Statement have not found higher prevalence of CLS among people on ART or those with viral load suppression. There have been few studies of sexual behaviour among people with HIV in the United Kingdom since the Swiss statement, and none that have examined associations of CLS with perceived (selfreported) viral load status -the crucial measure when considering impact on behaviour.
If ART use or perceived suppressed viral load was found to be associated with substantially higher levels of condomless sex (CLS), this could undermine the full impact of early ART on HIV transmission. This could occur if individuals on ARTwere not accurately assessing their viral load status (and therefore infectiousness to sexual partners) and modifying sexual behaviour accordingly. Also of importance is that lower condom use among people on ART may have an adverse effect on transmission of sexually transmitted infections other than HIV (STIs), the infectivity of which would not be lessened by ART use. Occurrence of STIs is high among HIV-diagnosed MSM [34, 35] .
The Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) study investigated sexual behaviour among people with HIV in the United Kingdom, and aimed to address the hypothesis that ART use and perceived undetectable viral load may be linked to CLS. This report assesses the association of self-reported ART/viral load status with CLS, in particular CLS with an HIV-serodifferent partner. In addition, as the protective effect of suppressed viral load on HIV infectiousness is now known with confidence, this report is the first to describe likely levels of CLS carrying an appreciable risk of HIV transmission (accounting for clinic-documented viral load level) according to selfreported ART/viral load. Although attitudes and behaviour in relation to condom use may be changing rapidly, as knowledge about transmission risk is disseminated and develops, the ASTRA results will also be important in establishing a baseline against which findings of future studies of HIV-positive people can be evaluated.
Methods
ASTRA recruited adults with diagnosed HIV attending eight hospital HIV outpatient clinics in the United Kingdom from February 2011 to December 2012. Full details have been described [36] . Participants selfcompleted a confidential sex-specific questionnaire on socio-demographic, HIV-related, health and lifestyle factors, and sexual behaviour. The latest documented viral load and CD4 þ cell count results that the participant had been informed of were collected from medical records. The study was approved by North West London REC 2 research ethics committee (ref 10/H0720/70). At the time of the study, the British HIV Association guidelines recommended ART initiation for HIVpositive people with a CD4 þ cell count of 350 cells/ml or less, unless special circumstances indicated earlier ART [37] .
Self-reported antiretroviral treatment/viral load Participants were asked about ever and current ART use. Those who ever started ARTwere asked their viral load at the last test, with three options: '50 copies/ml or less (undetectable or suppressed)'; 'more than 50 copies/ml (detectable or raised)' and 'don't know'. Self-reported ART/viral load was categorised into three groups: not on ART; on ARTwith undetectable self-reported viral load; on ART without undetectable self-reported viral load (including 'do not know' and missing self-reported viral load).
Sexual behaviour
The men's questionnaire asked about sex with women, and sex with men; the women's questionnaire asked about sex with men. Participants were asked whether, in the past 3 months, they had: anal or vaginal sex (and if so how many partners), sex without a condom (CLS), CLS with an HIV-positive person, CLS with an HIV-serodifferent (negative or unknown status) partner (CLS-D). Those reporting CLS-D were asked: number and type (longterm or other) of CLS-D partner(s); number of times had CLS-D (in categories); whether they ever ejaculated inside a partner during CLS-D (men only); position for anal CLS-D for MSM (always insertive; always receptive; both); reasons for not using a condom at last CLS-D (11 options including: 'I believe the risk of HIV transmission is very low'). Those who reported CLS, but did not indicate HIV status of partner(s), were classified as having 'possible CLS-D', but not included in the main definition. All participants were asked about group sex and new STI diagnoses in the past 3 months, and number of new sexual partners in the past year.
HIV-transmission risk sex
A variable was constructed to define sex with an appreciable risk of HIV transmission (CLS-D-HIV-risk). CLS-D-HIV-risk is a subset of CLS-D. An individual was positive for CLS-D-HIV-risk if, in addition to reporting CLS-D, they were either not on ART (self-reported) or had clinic-recorded viral load more than 50 copies/ml (using the single viral load documented for each participant). Individuals who reported CLS-D, but were on ART with clinic-recorded viral load 50 copies/ml or less were negative for CLS-D-HIV-risk.
Transmission risk beliefs
Participants rated their agreement (strongly agree, tend to agree, undecided/no opinion, tend to disagree and strongly disagree) with the following statements: 'An undetectable HIV viral load makes someone less infectious to a sexual partner than if they had a high viral load' and 'When viral load is undetectable, a condom is not needed to prevent HIV transmission'.
Statistical analysis
Individuals who reported an HIV diagnosis date less than 3 months before the date of questionnaire issue were excluded, to ensure reported sexual behaviour related to a period after diagnosis. Men who self-identified as gay or bisexual or reported sex with a man in the past 3 months were classified as MSM. Characteristics and sexual behaviour were summarised for: MSM, heterosexual men, women. Subsequent analyses were conducted separately for MSM and all heterosexual individuals. The combined heterosexual category was used to increase power; there was no evidence that associations differed between men and women. Unadjusted associations of self-reported ART/viral load and other factors with CLS-D, and CLS overall, were assessed using x 2 tests. Modified Poisson regression [38] was used to obtain unadjusted and adjusted prevalence ratios with 95% confidence intervals (CI), for association of self-reported ART/viral load with CLS-D. First, adjustment was made for socio-demographic and HIV-related factors: age group (<30 years; !30 years); black ethnicity (no/missing; yes); university education (no/missing; yes); identifying with a religion (no/missing; yes); time with diagnosed HIV (3 months to 1.9 years; 2-4.9 years; 5-9.9 years; 10-14.9 years; 15-19.9 years; !20 years) and partner status (HIV-positive; HIV-negative/unknown status; no stable partner). Age was used in two categories only because of collinearity with time with diagnosed HIV. In a second model, additional adjustment was made for higher alcohol intake (no/missing; yes, using score !6 on the first two WHO AUDIT-C [39] questions) and number of recreational drugs used in the past 3 months (none/missing; 1; 2-3; !4) [40] . In heterosexual models, categories were collapsed for some variables (see Table 4 ) and there was additional adjustment for sex. Model results were not materially altered by further adjustment for clinic, or when cases that had been excluded because of missing values in age, diagnosis date, partner status or selfreported ART/viral load were included using 'missing' categories. The prevalence of CLS-D-HIV-risk was described overall, and for MSM, and heterosexual men and women, according to self-reported ART/viral load.
Three sensitivity analyses were performed separately for MSM and heterosexual individuals. The association of self-reported ART/viral load with CLS-D was assessed: 
Results
Overall, 3258 people with diagnosed HIV participated in ASTRA (5112 invited: response rate 64%), of whom 80 are excluded as they had been diagnosed for less than 3 months. (Table 4a ). Attenuation of this latter effect ('not on ART' vs. 'ART with undetectable self-reported viral load') was primarily because of adjustment for time with diagnosed HIV. The significant difference in CLS-D between the two 'on ART' groups persisted after additional adjustment for alcohol and recreational drug use (Table 4a) .
Sexual behaviour and association with selfreported antiretroviral treatment/viral load among heterosexual men and women Table 3b shows associations for all heterosexual participants combined. Self-reported ART/viral load was not associated with CLS-D. CLS-D was associated with younger age, birth in the United Kingdom, non-black ethnicity, university education, not having a recent HIV diagnosis, higher CD4þ cell count and tended to be associated with greater financial security. CLS-D prevalence was much lower among the majority of individuals who identified with a religion than the minority who did not, and much higher among people with an HIV-negative/unknown status stable partner. CLS-D was associated with recreational drug use, but not with smoking or alcohol use. Patterns of association were broadly similar with all CLS. There remained no significant association of self-reported ART/viral load with CLS-D among heterosexual individuals in adjusted models (Table 4b ). 
Transmission risk beliefs
ART/viral load and CLS-D for sensitivity analyses a-c (data not shown).
Discussion
In this large multicentre study of people attending HIV clinics in the United Kingdom in 2011/12, use of ART was not associated with higher prevalence of CLS-D. Among MSM, those on ART had moderately lower prevalence of CLS-D than those not on ART, although this association was not independent of time since HIV diagnosis. Among MSM on ART, those who reported undetectable viral load had higher levels of CLS-D than those who did not, but CLS-D prevalence in both 'on ART' groups was lower than for MSM not on ART. Among heterosexual men and women, self-reported ART/viral load was not significantly associated with CLS-D. Patterns were similar for CLS overall. The prevalence of CLS-D-HIV-risk was low in the study population overall, and extremely low among those on ART with undetectable self-reported viral load.
With few exceptions [18, 21, 23] , previous epidemiological studies [19, 20, [22] [23] [24] [25] [26] [28] [29] [30] [31] [32] [33] have found either no association of CLS-D with ART use and/or suppressed viral load, or that people on ART had somewhat lower levels of CLS-D. Similarly, a randomized comparison within the SMART trial (2002) (2003) (2004) (2005) (2006) found that starting ART led to a reduction in CLS-D in the short term [27] . The most recent observational study used data from 2009, a few years prior to ASTRA. Interview-assessed sexual behaviour was linked to recorded viral load among a large sample of United States' HIV outpatients (Medical Monitoring Project) [33] . Self-reported viral load was not assessed. Similar to ASTRA results comparing 'on ART' with 'not on ART', the United States' study found ART and sexual behaviour Lampe 1753 
that individuals with viral load suppression had lower levels of sex, CLS, and CLS-D than those without; the association was significant only for MSM.
For MSM on ART in ASTRA, the prevalence of CLS-D was higher among those who reported undetectable viral load than among those who did not. This modest difference remained after adjustment for other factors, and among the subgroup of MSM who had recent sex (sensitivity analysis b), therefore was not due to those on ART being less likely to be sexually active. The difference was particularly marked among those more recently diagnosed (sensitivity analysis c). Although there may be other differences between the two 'on ART' groups, one plausible explanation is that some MSM were choosing not to use a condom with HIV-serodifferent partners because of knowledge of very low infectiousness based on their perceived viral load. Consistent with this, of all participants who reported CLS-D, belief that transmission risk was low was more frequently a reason for not using condoms among those with undetectable self-reported viral load than those without. However, if knowledge of viral load was influencing sexual behaviour among MSM, the effect appeared modest, because levels of CLS-D among those on ART with undetectable self-reported viral load did not exceed those for men not on ART.
Prevalence estimates of CLS-D among MSM (15%) and heterosexual men (6%) and women (11%) with HIV in ASTRA are similar to those from two clinic-based studies in the United Kingdom in 2004-2005 using an identical definition (20 and 15% among 758 [22] and 451 [29] MSM, respectively; less than 10% among heterosexual men and women [22, 29] ), and from the European START trial participants at baseline: 15, 3 and 10% in the past 2 months for 1518 MSM, 207 heterosexual men and 138 women with HIV not taking ART (recently diagnosed participants were included) [41] . The START analysis found no significant trend in baseline CLS-D prevalence over the recruitment period (2009) (2010) (2011) (2012) (2013) ASTRA is the largest questionnaire study of sexual behaviour among people living with HIV in the United Kingdom; although power to assess associations among heterosexual men and women separately was limited.
Participants were reassured that questionnaire responses were confidential and would not be seen by clinic staff. Nevertheless, self-reported behaviour and attitudes may be subject to errors and social desirability bias.
What are the implications of these results for HIVtransmission? The prevalence of 'HIV-transmission risk sex' was much lower among those on ART vs. not on ART (1.4% vs 16.1%), and less than 1% among those on ART with undetectable self-reported viral load. Even if the ASTRA results do indicate the start of a trend of increasingly higher levels of CLS-D with perceived undetectable viral load (among MSM or the HIVdiagnosed population overall), prevalence of CLS-D-HIV-risk will likely continue to remain far lower among those on ART with undetectable self-reported viral load than among those not on ART. This is because of the effectiveness of ART and the apparent high accuracy of self-reported undetectable viral load status in this population. These results highlight the importance, as ART use expands, of promoting sustained high adherence, regular viral load testing, and on-going awareness of personal viral load level. It is also important to note that the definition of CLS-D-HIV-risk used here is based on the single clinic viral load measurement collected for all ASTRA participants, assumes elimination of risk with viral suppression on ART (as assumed with condom use), and does not incorporate factors such as self-reported ART non-adherence or presence of other STIs, the additional impact of which are uncertain [13, 48] .
In terms of transmission of other STIs, CLS overall is the most relevant measure. Similar to CLS-D, CLS prevalence among MSM was highest for those not on ART with no significant difference by ART use among heterosexual individuals. Therefore these data give little suggestion that expansion of ARTuse will have a negative impact on STI transmission. Nevertheless, the high prevalence of CLS compared with CLS-D-HIV risk, and the possibility that levels of CLS among those with undetectable self-reported viral load may continue to increase, emphasise the importance of ongoing promotion of condom use, STI prevention and testing among people with HIV.
The ASTRA study was planned in the period following the Swiss statement, which was then hugely controversial [49] . During recruitment, results were released from HPTN 052 [12] ; PARTNER results were first presented after completion of ASTRA [13] . During this period United Kingdom [37] and other [50, 51] treatment guidelines were changed to recommend discussing with HIV-positive people the beneficial effect of ART on infectiousness. The extent to which, and the rapidity with which, these findings and recommendations may influence the sexual behaviour of people with HIV [52] , or change the long-standing culture of condom use [3] , is unclear.
With increasing use of early ART, it will be important to continue monitoring the association between ART and CLS, not only to understand the impact on HIV transmission, but also to assess implications for transmission of hepatitis C and other STIs.
In conclusion, among people with HIV in the United Kingdom, use of ART was not associated with increased prevalence of CLS or CLS-D, and was associated with greatly reduced prevalence of HIV-transmission risk sex. Although there was evidence that perceived undetectable viral load may influence condom use among MSM, any such effect was modest at the time of the study, and would not undermine the effect of early ART on HIV/STI transmission. These results support the prevention role of ART offered to all people with HIV, and emphasise the need to focus on HIV/STI prevention among those not on ART.
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